Skip to main content

A Boston startup is making a blood test for ovarian cancer

This new test will look at recently-discovered markers in a patient's blood that could tell providers whether a patient is at high risk or low risk for ovarian cancer.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.